Table 1.
Demographic, medical background and infectious agents involved in IE hospitalizations
| 2010–2018 | |
|---|---|
| Number of patients, n | 7574 |
| Male, n (%) | 4308 (56.9) |
| Age, years (SD) | 68.3 ± 17.3 |
| Age groups, n (%) | |
| < 18 | 91 (1.2) |
| 18–39 | 503 (6.6) |
| 40–59 | 1253 (16.5) |
| 60–79 | 3565 (47.1) |
| ≥ 80 | 2162 (28.5) |
| Length of hospital stay, days (SD) |
29.3 ± 28.7 Median 21 |
| Medical background, n (%) | |
| Diabetes mellitus | 2016 (26.6) |
| Arterial hypertension | 2828 (37.3) |
| Atrial fibrillation | 1876 (24.8) |
| HIV | 133 (1.8) |
| CRF | 887 (11.7) |
| CRF on Hemodialysis | 324 (4.3) |
| Non-rheumatic cardiac valve disease | 1590 (21.0) |
| Rheumatic valve disease | 709 (9.4) |
| Cardiac valve prosthesis | 914 (12.1) |
| Cardiac implantable electronic devices | 649 (8.6) |
| Coronary artery disease | 970 (12.8) |
| Previous PCI | 108 (1.4) |
| Previous CABG | 183 (2.4) |
| Congenital heart disease | 42 (1.0) |
| Cancer | 1018 (13.4) |
| COPD | 702 (9.3) |
| Opioid consumption | 103 (1.4) |
| Chronic hepatic disease | 366 (4.8) |
| Infectious agents, n (%) | |
| Staphylococcus | 1242 (16.4) |
| Streptococcus | 1030 (13.6) |
| Enterococcus | 535 (7.1) |
| Gram-negative | 898 (11.9) |
| Anaerobes | 20 (0.3) |
| Fungi | 10 (0.1) |
| Brucella | 9 (0.1) |
CABG coronary artery bypass graft, COPD Chronic Obstructive Pulmonary Disease, CRF chronic renal failure, HIV human immunodeficiency virus, PCI percutaneous coronary intervention